feed,title,long_url,short_url
Benzinga,FDA Approves Expanded Use Of Novartis' Rare Disease Drug Fabhalta For Kidney Disease,https://benzinga.com/general/biotech/24/08/40254535/fda-approves-expanded-use-of-novartis-rare-disease-drug-fabhalta-for-kidney-disease,https://da.gd/gSAZv
Benzinga,"Shift4 Payments Q2 Earnings: Revenue Surges 30%, Subscription Revenue Doubles",https://benzinga.com/news/earnings/24/08/40254472/shift4-payments-q2-earnings-revenue-surges-30-subscription-revenue-doubles,https://da.gd/vrGKPb
